Mounjaro (Tirzepatide), a groundbreaking GLP-1 receptor agonist targeting GIP receptors, is now available in India for ...

Amy Schumer endorses the new weight loss drug Mounjaro, praising its effectiveness after an adverse experience with Wegovy.

Amy Schumer’s experience with Mounjaro has been vastly different from when she tried an alternative weight-loss medication ...

Schumer said she was having success on Mounjaro after previously being unable to "handle" Ozempic's side effects.

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

The comedian shared in an Instagram video that she previously tried Wegovy three years ago but she "couldn't handle it" ...

Glucagon-like peptide-1 agonists, a class of medications known as GLP-1s, have grown in popularity, initially for the ...

Eli Lilly launches Mounjaro in India, targeting the $150B weight-loss market. The GLP-1 drug offers diabetes control & major ...

Obesity remains a significant public health challenge in the UK, with over 26% of adults classified as obese and an ...

Amy Schumer has opened up about her current health journey, revealing that she’s seeing strong results using the weight loss ...

As research continues, Mounjaro may redefine medical weight loss strategies, but its ethical implications and long-term ...

The global weight-loss drug market is expected to reach $150 billion in the next decade. By 2026, semaglutide (the active ...